Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to $47.6 million.

  • Sanara MedTech's Total Non-Current Liabilities rose 3694.46% to $47.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.6 million, marking a year-over-year increase of 3694.46%. This contributed to the annual value of $33.9 million for FY2024, which is 11842.99% up from last year.
  • As of Q3 2025, Sanara MedTech's Total Non-Current Liabilities stood at $47.6 million, which was up 3694.46% from $48.5 million recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Total Non-Current Liabilities ranged from a high of $48.5 million in Q2 2025 and a low of $187040.0 during Q1 2022
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $7.9 million (2023), whereas its average is $16.6 million.
  • Per our database at Business Quant, Sanara MedTech's Total Non-Current Liabilities tumbled by 6512.55% in 2021 and then soared by 411663.12% in 2023.
  • Sanara MedTech's Total Non-Current Liabilities (Quarter) stood at $222151.0 in 2021, then soared by 2830.03% to $6.5 million in 2022, then surged by 138.36% to $15.5 million in 2023, then skyrocketed by 118.43% to $33.9 million in 2024, then surged by 40.43% to $47.6 million in 2025.
  • Its last three reported values are $47.6 million in Q3 2025, $48.5 million for Q2 2025, and $46.4 million during Q1 2025.